Legend Biotech US is a global biotechnology company headquartered in Somerset, New Jersey, focused on developing advanced cell therapies to treat and potentially cure life-threatening diseases. The company utilizes a variety of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell therapies, T-cell receptor (TCR-T) therapies, and natural killer (NK) cell-based immunotherapy. With three R&D sites worldwide, Legend Biotech is committed to discovering safe and effective therapeutics for patients globally. The company has established a strategic partnership with Janssen, a subsidiary of Johnson & Johnson, to collaboratively develop and commercialize innovative immunotherapy solutions for multiple myeloma.